FibroGen Market Cap

FibroGen has a market cap or net worth of $105.69 million as of April 24, 2024. Its market cap has decreased by -94.55% in one year.

Market Cap

105.69M

Enterprise Value

74.06M

1-Year Change

-94.55%

Ranking

#4076

Market Cap Chart

Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $105.69M, a decrease of -91.37%. That is a compound annual growth rate of -22.85%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	105.70M	-6.13%
Apr 22, 2024	112.60M	-0.88%
Apr 19, 2024	113.60M	-1.73%
Apr 18, 2024	115.60M	-7.81%
Apr 17, 2024	125.40M	-2.34%
Apr 16, 2024	128.40M	-0.77%
Apr 15, 2024	129.40M	0.78%
Apr 12, 2024	128.40M	-4.39%
Apr 11, 2024	134.30M	-4.89%
Apr 10, 2024	141.20M	-5.30%
Apr 9, 2024	149.10M	-7.39%
Apr 8, 2024	161.00M	0.63%
Apr 5, 2024	160.00M	2.50%
Apr 4, 2024	156.10M	7.51%
Apr 3, 2024	145.20M	-31.93%
Apr 2, 2024	213.30M	-8.49%
Apr 1, 2024	233.10M	0.43%
Mar 28, 2024	232.10M	-8.91%
Mar 27, 2024	254.80M	5.73%
Mar 26, 2024	241.00M	-7.59%
Mar 25, 2024	260.80M	2.35%
Mar 22, 2024	254.80M	6.17%
Mar 21, 2024	240.00M	2.96%
Mar 20, 2024	233.10M	0.43%
Mar 19, 2024	232.10M	8.31%

View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Vor Biopharma	116.65M
Adagene	116.47M
Coya Therapeutics	116.34M
InterCure	115.30M
Cardiol Therapeutics	115.25M
CytomX Therapeutics	113.10M
Neuronetics	113.07M
Inotiv	111.42M

Market Cap Rankings